PERSPECTA

News from every angle

← Back to headlines

Ardelyx Stock Declines Following Xphozah Appeal Setback

Ardelyx shares experienced a decline after the company faced a setback in its appeal regarding the drug Xphozah.

26 Jun, 18:41 — 26 Jun, 18:41
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed1h ago

Ardelyx stock decline attributed to setback in Xphozah appeal

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Americold-EQT Joint Venture Granted Early FTC Termination

17m ago

Argus Initiates Coverage on SpaceX with Hold Rating

18m ago

Danish Home Goods Retailer Flying Tiger Opens First Canadian Store

20m ago